<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0051">
 <label>51</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Peng</surname>
    <given-names>F-W</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>D-K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>Q-W</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012–2016)</article-title>. 
  <source>Expert Opin Ther Pat</source>
  <year>2017</year>;
  <volume>27</volume>:
  <fpage>987</fpage>–
  <lpage>1004</lpage>.
  <pub-id pub-id-type="pmid">28621580</pub-id>
 </mixed-citation>
</ref>
